These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6283345)

  • 1. Myelomatosis with type III hyperlipoproteinemia: clinical and metabolic studies.
    Cortese C; Lewis B; Miller NE; Peyman MA; Rao SN; Slavin B; Sule U; Turner PR; Utermann G; Wing AJ; Weight M; Wootton R
    N Engl J Med; 1982 Jul; 307(2):79-83. PubMed ID: 6283345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G; Beltz WF; Grundy SM; Howard BV
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia.
    Turner PR; Cortese C; Wootton R; Marenah C; Miller NE; Lewis B
    Eur J Clin Invest; 1985 Apr; 15(2):100-12. PubMed ID: 3922766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDL, VLDL, chylomicrons and atherosclerosis.
    Nordestgaard BG; Tybjaerg-Hansen A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():92-8. PubMed ID: 1505659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.
    Packard CJ; Clegg RJ; Dominiczak MH; Lorimer AR; Shepherd J
    J Lipid Res; 1986 Sep; 27(9):930-8. PubMed ID: 3783047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat.
    Musliner TA; McVicker KM; Iosefa JF; Krauss RM
    Arteriosclerosis; 1987; 7(4):408-20. PubMed ID: 3606468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoproteins and arteriosclerosis].
    Shinomiya M; Morisaki N; Murano S; Sasaki N; Shirai K; Matsuoka N; Saito Y; Kumagai A
    Nihon Rinsho; 1980 Jul; 38(7):2798-814. PubMed ID: 7007691
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of thyroid hormones to human plasma lipoproteins.
    Benvenga S; Gregg RE; Robbins J
    J Clin Endocrinol Metab; 1988 Jul; 67(1):6-16. PubMed ID: 3379137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.
    Falko JM; Schonfeld G; Witztum JL; Kolar JB; Weidman SW; Steelman R
    J Clin Endocrinol Metab; 1980 Mar; 50(3):521-8. PubMed ID: 7358833
    [No Abstract]   [Full Text] [Related]  

  • 20. The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia.
    Reardon MF; Poapst ME; Steiner G
    Metabolism; 1982 May; 31(5):421-7. PubMed ID: 7078425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.